P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS

Bibliographic Details
Main Authors: Sjoerd Hermans, Yvette van Norden, Erik van Werkhoven, Avinash Dinmohamed, Peter Huijgens, Gert Ossenkoppele, Gerwin Huls, Bob Löwenberg, Thomas Pabst, Dimitri Breems, Douwe Postmus, Francesco Pignatti, Jurjen Versluis, Jan Cornelissen
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000969164.32364.1c
_version_ 1797280126524719104
author Sjoerd Hermans
Yvette van Norden
Erik van Werkhoven
Avinash Dinmohamed
Peter Huijgens
Gert Ossenkoppele
Gerwin Huls
Bob Löwenberg
Thomas Pabst
Dimitri Breems
Douwe Postmus
Francesco Pignatti
Jurjen Versluis
Jan Cornelissen
author_facet Sjoerd Hermans
Yvette van Norden
Erik van Werkhoven
Avinash Dinmohamed
Peter Huijgens
Gert Ossenkoppele
Gerwin Huls
Bob Löwenberg
Thomas Pabst
Dimitri Breems
Douwe Postmus
Francesco Pignatti
Jurjen Versluis
Jan Cornelissen
author_sort Sjoerd Hermans
collection DOAJ
first_indexed 2024-03-07T16:36:42Z
format Article
id doaj.art-c16caf3ba82a4bbb882f171f37e1d875
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:36:42Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-c16caf3ba82a4bbb882f171f37e1d8752024-03-03T09:43:32ZengWileyHemaSphere2572-92412023-08-017e323641c10.1097/01.HS9.0000969164.32364.1c202308003-00465P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTSSjoerd Hermans0Yvette van Norden1Erik van Werkhoven2Avinash Dinmohamed3Peter Huijgens4Gert Ossenkoppele5Gerwin Huls6Bob Löwenberg7Thomas Pabst8Dimitri Breems9Douwe Postmus10Francesco Pignatti11Jurjen Versluis12Jan Cornelissen131 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands1 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands1 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands3 Netherlands Comprehensive Cancer Organisation (IKNL), Research and Development, Utrecht, The Netherlands3 Netherlands Comprehensive Cancer Organisation (IKNL), Research and Development, Utrecht, The Netherlands4 Amsterdam University Medical Centers, Vrije Universiteit Medical Center, Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands5 University Medical Center Groningen (UMCG), Hematology, Groningen, The Netherlands1 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands6 Inselspital, Bern University Hospital, Department of Medical Oncology, Bern, Switzerland7 Ziekenhuis Netwerk Antwerpen, Hematology, Antwerpen, Belgium8 University of Groningen, University Medical Center Groningen, Epidemiology, Groningen, The Netherlands9 European Medicines Agency, Oncology and Hematology Office, Amsterdam, The Netherlands1 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands1 Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlandshttp://journals.lww.com/10.1097/01.HS9.0000969164.32364.1c
spellingShingle Sjoerd Hermans
Yvette van Norden
Erik van Werkhoven
Avinash Dinmohamed
Peter Huijgens
Gert Ossenkoppele
Gerwin Huls
Bob Löwenberg
Thomas Pabst
Dimitri Breems
Douwe Postmus
Francesco Pignatti
Jurjen Versluis
Jan Cornelissen
P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
HemaSphere
title P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
title_full P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
title_fullStr P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
title_full_unstemmed P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
title_short P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
title_sort p565 real world data as supplementary controls for the prospective randomized hovon 103 trial in intensively treated elderly acute myeloid leukemia patients
url http://journals.lww.com/10.1097/01.HS9.0000969164.32364.1c
work_keys_str_mv AT sjoerdhermans p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT yvettevannorden p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT erikvanwerkhoven p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT avinashdinmohamed p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT peterhuijgens p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT gertossenkoppele p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT gerwinhuls p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT boblowenberg p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT thomaspabst p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT dimitribreems p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT douwepostmus p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT francescopignatti p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT jurjenversluis p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients
AT jancornelissen p565realworlddataassupplementarycontrolsfortheprospectiverandomizedhovon103trialinintensivelytreatedelderlyacutemyeloidleukemiapatients